Clinical Trials Browser

Neuroendocrine Tumors

NCT04979611 2023-09-21

The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma

Phase 1 Unknown

60 enrolled

Endocrine

Insulinoma

NCT02693067 2023-02-08

A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver

Phase 1 Unknown

12 enrolled

EndocrineNET

Neuroendocrine Tumors Metastatic to the Liver

NCT00986661 2022-11-02

A Study to Assess PV-10 Chemoablation of Cancer of the Liver

Phase 1 Unknown

78 enrolled

BreastDermatologicEndocrineGastrointestinalThoracic

Uveal Melanoma, Breast Neoplasms, Carcinoid Tumor, Colonic Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms

NCT03478358 2022-08-31

Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Phase 1 Unknown

60 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT02637531 2022-04-04

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

Phase 1 Unknown

219 enrolled

BreastDermatologicEndocrineOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Mesothelioma, Adrenocortical Carcinoma, Triple Negative Breast Neoplasms

NCT03734913 2020-07-22

A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors

Phase 1 Unknown

65 enrolled

CNSDermatologicEndocrineNETThoracic

Carcinoma, Basal Cell, Glioblastoma, Medulloblastoma, Neuroendocrine Tumors, Small Cell Lung Carcinoma

NCT03404414 2018-01-19

Detection of Functioning Pituitary Microadenoma: PET/MRI Versus PET/CT

Phase 1 Unknown

100 enrolled

Endocrine

Pituitary Neoplasms

NCT03308682 2017-10-12

177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Phase 1 Unknown

30 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT02970786 2016-11-22

Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans

Phase 1 Unknown

10 enrolled

BreastEndocrineGynecologic

Breast Neoplasms, Ovarian Neoplasms, Carcinoma, Neuroendocrine

NCT00103155 2013-09-20

Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer

Phase 1 Unknown

EndocrineHead & Neck

Thyroid Cancer, Papillary, Head and Neck Neoplasms

NCT00314925 2010-02-25

Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features

Phase 1 Unknown

60 enrolled

CNSEndocrineGenitourinaryOther solid neoplasmSarcoma

Carcinoid Tumor, Glioblastoma, Medulloblastoma, Wilms Tumor, Neuroblastoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Rhabdomyosarcoma, Alveolar

Clinical Trials

177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors

The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma

A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver

A Study to Assess PV-10 Chemoablation of Cancer of the Liver

Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors

Detection of Functioning Pituitary Microadenoma: PET/MRI Versus PET/CT

177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans

Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer

Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features